Detailed FISH Analysis of HER2 2+Immunohistochemistry Cases: Rarity of Cases with High Level HER2 Gene Amplification

被引：0
|
作者：
Gingell, D. C. [1 ]
Dabbs, D. J. [1 ]
Surti, U. [1 ]
Bhargava, R. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
179
引用
收藏
页码：42A / 42A
页数：1
相关论文
共 50 条
  • [31] A comparison of two HER2 FISH methods to measure HER2 amplification and predict clinical outcome
    Dressler, LG
    Broadwater, G
    Berry, D
    Cirrincione, C
    Cowan, D
    Harris, L
    Moore, D
    Muss, H
    Hayes, D
    Ellis, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 18S - 18S
  • [32] Comparative Analysis of Four Immunohistochemical Assays for HER2 Expression in Breast Carcinoma - Correlation with HER2 Gene Amplification and Perspectives for HER2 Low Expression
    Nielsen, Soren
    Wang, Diana
    Calero, Valeria Montalvo
    LaMar, Jared
    Saxena, Ashish
    Decamillis, Rina
    Stensballe, Mia
    LABORATORY INVESTIGATION, 2023, 103 (03) : S192 - S192
  • [33] Evaluation of HER2 IHC Staining Using the Ventana Image Analysis System, Correlation with HER2 FISH Amplification
    Dennis, J. A.
    Parsa, R.
    Chau, D.
    Peng, Y.
    Sahoo, S.
    Fang, Y. V.
    Sarode, V. R.
    MODERN PATHOLOGY, 2013, 26 : 36A - 36A
  • [34] Evaluation of HER2 IHC Staining Using the Ventana Image Analysis System, Correlation with HER2 FISH Amplification
    Dennis, J. A.
    Parsa, R.
    Chau, D.
    Peng, Y.
    Sahoo, S.
    Fang, Y. V.
    Sarode, V. R.
    LABORATORY INVESTIGATION, 2013, 93 : 36A - 36A
  • [35] Analysis of equivocal HER2 FISH amplification in breast cancer
    Sung, S. H.
    Moon, B. I.
    HISTOPATHOLOGY, 2012, 61 : 30 - 30
  • [36] HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+Breast Cancer With Early Recurrence
    Yamashita, Hiroko
    Ishida, Naoko
    Hatanaka, Yutaka
    Hagio, Kanako
    Oshino, Tomohiro
    Takeshita, Takashi
    Kanno-Okada, Hiromi
    Shimizu, Ai
    Hatanaka, Kanako C.
    Matsuno, Yoshihiro
    ANTICANCER RESEARCH, 2020, 40 (02) : 645 - 652
  • [37] HER2 testing: Insights from pathologists' perspective on challenging HER2 cases.
    Grimm, Erin V.
    Swenson, Karen K.
    Krueger, Janet
    Hicks, David G.
    Allison, Kimberly H.
    Yaziji, Hadi
    Rendi, Mara Hester
    Susnik, Barbara
    Downs-Kelly, Erinn
    Tsai, Michaela L.
    Lillemoe, Tamera J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] HER2 or not HER2: That is the question
    Burstein, HJ
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3656 - 3659
  • [39] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [40] Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
    Yano, T
    Doi, T
    Ohtsu, A
    Boku, N
    Hashizume, K
    Nakanishi, M
    Ochiai, A
    ONCOLOGY REPORTS, 2006, 15 (01) : 65 - 71
12345